TABLE III.
Demographic characteristics for the top 10 trajectories
| Care trajectorya | Pts [n(%)] | Mean age (years) | Age group [ n (%)] | Sex [n(%)] | Neighbourhood income quintile [n(%)] | Rurality [ n(%)] | Multimorbidity at cancer diagnosis [n(%)] | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|||||||||||||||||
| 18–44 Years | 45–64 Years | 65–74 Years | 75–84 Years | 85+ Years | Women | Men | 1 (lowest) | 2 | 3 | 4 | 5 (highest) | Urban | Rural | 0 | 1 | 2 | 3 | 4+ | |||
| Low–Survived–Low | 27,896 (31.4) | 58.5±13.2 | 3,810 (13.7) | 15,092 (54.1) | 6,003 (21.5) | 2,498 (9.0) | 493 (1.8) | 14,773 (53.0) | 13,123 (47.0) | 4,212 (15.1) | 5,231 (18.8) | 5,496 (19.7) | 6,172 (22.1) | 6,685 (24.0) | 24,220 (86.8) | 3,654 (13.1) | 9,015 (32.3) | 8,973 (32.2) | 5,920 (21.2) | 2,770 (9.9) | 1218 (4.4) |
| Low–Survived–High | 13,004 (14.7) | 64.4±13.1 | 992 (7.6) | 5,087 (39.1) | 3,927 (30.2) | 2,457 (18.9) | 541 (4.2) | 6,120 (47.1) | 6,884 (52.9) | 2,289 (17.6) | 2,591 (19.9) | 2,529 (19.4) | 2,697 (20.7) | 2,862 (22.0) | 11,135 (85.6) | 1,863 (14.3) | 2,735 (21.0) | 3,662 (28.2) | 3,347 (25.7) | 1,971 (15.2) | 1289 (9.9) |
| Low–Ongoing | 4,518 (5.1) | 58.2±13.0 | 636 (14.1) | 2,444 (54.1) | 978 (21.6) | 399 (8.8) | 61 (1.4) | 2,659 (58.9) | 1,859 (41.1) | 743 (16.4) | 846 (18.7) | 921 (20.4) | 1,004 (22.2) | 988 (21.9) | 3,917 (86.7) | 600 (13.3) | 1,487 (32.9) | 1,402 (31.0) | 931 (20.6) | 454 (10.0) | 244 (5.4) |
| Low–Died | 8,054 (9.1) | 66.9±12.9 | 320 (4.0) | 3,146 (39.1) | 2,131 (26.5) | 1,796 (22.3) | 661 (8.2) | 3,654 (45.4) | 4,400 (54.6) | 1,672 (20.8) | 1,748 (21.7) | 1,534 (19.0) | 1,578 (19.6) | 1,485 (18.4) | 6,794 (84.4) | 1,253 (15.6) | 2,088 (25.9) | 2,212 (27.5) | 1,918 (23.8) | 1,129 (14.0) | 707 (8.8) |
| Low–Survived–Died | 3,779 (4.3) | 69.0±12.9 | 118 (3.1) | 1,268 (33.6) | 974 (25.8) | 987 (26.1) | 432 (11.4) | 1,698 (44.9) | 2,081 (55.1) | 834 (22.1) | 822 (21.8) | 731 (19.3) | 697 (18.4) | 682 (18.0) | 3,220 (85.2) | 556 (14.7) | 951 (25.2) | 955 (25.3) | 913 (24.2) | 551 (14.6) | 409 (10.8) |
| High–Survived–Low | 5,258 (5.9) | 64.7±14.3 | 535 (10.2) | 1,759 (33.5) | 1,572 (29.9) | 1,120 (21.3) | 272 (5.2) | 2,541 (48.3) | 2,717 (51.7) | 961 (18.3) | 1,028 (19.6) | 1,015 (19.3) | 1,112 (21.1) | 1,122 (21.3) | 4,499 (85.6) | 757 (14.4) | 778 (14.8) | 1,289 (24.5) | 1,351 (25.7) | 977 (18.6) | 863 (16.4) |
| High–Survived–High | 11,322 (12.8) | 71.9±11.8 | 308 (2.7) | 2,051 (18.1) | 3,763 (33.2) | 3,851 (34.0) | 1,349 (11.9) | 5,405 (47.7) | 5,917 (52.3) | 2,434 (21.5) | 2,399 (21.2) | 2,202 (19.4) | 2,138 (18.9) | 2,108 (18.6) | 9,740 (86.0) | 1,577 (13.9) | 563 (5.0) | 1,297 (11.5) | 2,352 (20.8) | 2,627 (23.2) | 4483 (39.6) |
| High–Ongoing | 1,869 (2.1) | 66.9±13.1 | 109 (5.8) | 580 (31.0) | 613 (32.8) | 447 (23.9) | 120 (6.4) | 907 (48.5) | 962 (51.5) | 401 (21.5) | 373 (20.0) | 343 (18.4) | 374 (20.0) | 370 (19.8) | 1,599 (85.6) | 270 (14.4) | 182 (9.7) | 371 (19.9) | 436 (23.3) | 388 (20.8) | 492 (26.3) |
| High–Died | 8,212 (9.3) | 74.4±11.2 | 126 (1.5) | 1,281 (15.6) | 2,272 (27.7) | 3,081 (37.5) | 1,452 (17.7) | 3,894 (47.4) | 4,318 (52.6) | 1,840 (22.4) | 1,751 (21.3) | 1,557 (19.0) | 1,562 (19.0) | 1,476 (18.0) | 7,036 (85.7) | 1,173 (14.3) | 543 (6.6) | 1,073 (13.1) | 1,672 (20.4) | 1,794 (21.8) | 3130 (38.1) |
| High–Survived–Died | 4,837 (5.5) | 76.0±11.0 | 39 (0.8) | 668 (13.8) | 1,152 (23.8) | 1,862 (38.5) | 1,116 (23.1) | 2,343 (48.4) | 2,494 (51.6) | 1,178 (24.4) | 1,033 (21.4) | 900 (18.6) | 906 (18.7) | 806 (16.7) | 4,148 (85.8) | 688 (14.2) | 238 (4.9) | 535 (11.1) | 928 (19.2) | 1,033 (21.4) | 2103 (43.5) |
a
Pre-cancer cost, outcome during cancer episode, post-cancer cost.